Study: NCT02260921

Adverse event: Myocardial infarction
Serious: yes
Organ System: Cardiac disorders
Frequency: 1 affected / 121 at risk

Adverse event: Acute myocardial infarction
Serious: yes
Organ System: Cardiac disorders
Frequency: 1 affected / 121 at risk

Adverse event: Lung neoplasm malignant
Serious: yes
Organ System: Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Frequency: 1 affected / 121 at risk

Adverse event: Administration site bruise
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 93 affected / 121 at risk

Adverse event: Administration site dysaesthesia
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 25 affected / 121 at risk

Adverse event: Administration site pain
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 26 affected / 121 at risk

Adverse event: Administration site paraesthesia
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 17 affected / 121 at risk

Adverse event: Administration site scab
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 6 affected / 121 at risk

Adverse event: Administration site swelling
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 49 affected / 121 at risk

Adverse event: Application site discolouration
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 1 affected / 121 at risk

Adverse event: Application site pruritus
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 7 affected / 121 at risk

Adverse event: Application site hypoaesthesia
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 63 affected / 121 at risk

Adverse event: Application site erythema
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 50 affected / 121 at risk

Adverse event: Application site pain
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 46 affected / 121 at risk

Adverse event: Pulmonary embolism
Serious: yes
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 1 affected / 59 at risk

Adverse event: Administration site bruise
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 31 affected / 59 at risk

Adverse event: Administration site dysaesthesia
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 11 affected / 59 at risk

Adverse event: Administration site pain
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 11 affected / 59 at risk

Adverse event: Administration site paraesthesia
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 59 at risk

Adverse event: Administration site scab
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 3 affected / 59 at risk

Adverse event: Administration site swelling
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 16 affected / 59 at risk

Adverse event: Application site pruritus
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 2 affected / 59 at risk

Adverse event: Application site hypoaesthesia
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 32 affected / 59 at risk

Adverse event: Application site erythema
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 24 affected / 59 at risk

Adverse event: Application site pain
Serious: no
Organ System: Skin and subcutaneous tissue disorders
Frequency: 23 affected / 59 at risk